Insulin for Hyperglycemia in Stroke Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

452

Participants

Timeline

Start Date

April 5, 2021

Primary Completion Date

June 20, 2021

Study Completion Date

June 25, 2021

Conditions
HyperglycemiaStroke, Acute
Interventions
DRUG

Analog Insulin

"For a patient who is known to have diabetes but were not getting insulin previously (or previous insulin dosage is not known), insulin therapy will be started at a total daily dose of 0.3-0.4 units/kg/day for an admission BG between 10-15 mmol/L or 0.5-0.6 units/kg/day for a BG \>15 mmol/L. In previously insulin treated patients, ongoing total daily dose of insulin will be started. If there is history of poor glycemic control with ongoing insulin dose, then 10-20% increase of daily dose of insulin will be considered.~For a patient who is not known to have diabetes, insulin therapy will be started if admission BG is \>10 mmol/L in two or more occasions. A total daily dose of 0.3-0.4 units/kg/day will be started if admission BG is 10-15 mmol/L and 0.5-0.6 units/kg/day for a BG \>15 mmol/L."

DRUG

Human insulin

Patients treated with human insulin regimen will receive 50% of total daily dose as NPH insulin at around 6 am and 6 pm, while the rest 50% regular human insulin three times a day in 3 equally divided doses at around 6 am, 12 pm and 6 pm.

Trial Locations (1)

1207

National Institute of Neurosciences and Hospital, Dhaka

All Listed Sponsors
lead

National Institute of Neurosciences and Hospital, Dhaka

OTHER_GOV

NCT04834362 - Insulin for Hyperglycemia in Stroke Trial | Biotech Hunter | Biotech Hunter